Stanford researchers build a virtual biotech company staffed by 37,000 AI agents
The agents linked cell-specific drug targets to better clinical trial outcomes. They also proposed a lung cancer treatment strategy matching one independently pursued by a drugmaker. Stanford researchers have built a system of more than 37,000 AI agents to sift...